Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics Operating Margin 2010-2025 | CORT

Current and historical operating margin for Corcept Therapeutics (CORT) over the last 10 years. The current operating profit margin for Corcept Therapeutics as of March 31, 2025 is 19.33%.
  
Corcept Therapeutics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $0.69B $0.11B 16.18%
2024-12-31 $0.68B $0.14B 20.41%
2024-09-30 $0.63B $0.15B 23.05%
2024-06-30 $0.57B $0.13B 22.63%
2024-03-31 $0.52B $0.12B 23.47%
2023-12-31 $0.48B $0.11B 22.36%
2023-09-30 $0.45B $0.10B 21.73%
2023-06-30 $0.43B $0.10B 23.08%
2023-03-31 $0.41B $0.10B 24.15%
2022-12-31 $0.40B $0.11B 27.86%
2022-09-30 $0.40B $0.13B 31.91%
2022-06-30 $0.39B $0.13B 33.42%
2022-03-31 $0.38B $0.13B 34.65%
2021-12-31 $0.37B $0.13B 34.15%
2021-09-30 $0.35B $0.12B 33.71%
2021-06-30 $0.34B $0.11B 31.49%
2021-03-31 $0.34B $0.11B 32.65%
2020-12-31 $0.35B $0.13B 36.44%
2020-09-30 $0.36B $0.13B 37.36%
2020-06-30 $0.35B $0.14B 40.06%
2020-03-31 $0.34B $0.13B 39.10%
2019-12-31 $0.31B $0.11B 36.48%
2019-09-30 $0.29B $0.10B 35.66%
2019-06-30 $0.27B $0.09B 34.33%
2019-03-31 $0.26B $0.09B 34.11%
2018-12-31 $0.25B $0.09B 35.86%
2018-09-30 $0.24B $0.09B 36.71%
2018-06-30 $0.22B $0.08B 36.11%
2018-03-31 $0.19B $0.07B 36.84%
2017-12-31 $0.16B $0.05B 33.75%
2017-09-30 $0.13B $0.04B 28.24%
2017-06-30 $0.11B $0.03B 23.64%
2017-03-31 $0.09B $0.02B 15.96%
2016-12-31 $0.08B $0.01B 13.41%
2016-09-30 $0.07B $0.01B 10.96%
2016-06-30 $0.06B $0.01B 7.81%
2016-03-31 $0.06B $0.00B 3.57%
2015-12-31 $0.05B $0.00B -6.00%
2015-09-30 $0.04B $-0.01B -18.18%
2015-06-30 $0.04B $-0.01B -34.21%
2015-03-31 $0.03B $-0.02B -59.38%
2014-12-31 $0.03B $-0.03B -107.69%
2014-09-30 $0.02B $-0.04B -166.67%
2014-06-30 $0.02B $-0.04B -235.29%
2014-03-31 $0.01B $-0.04B -338.46%
2013-12-31 $0.01B $-0.04B -381.82%
2013-09-30 $0.01B $-0.04B -525.00%
2013-06-30 $0.01B $-0.04B -666.67%
2013-03-31 $0.01B $-0.04B -740.00%
2009-12-31 $0.00B $-0.02B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.725B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.33
Zoetis (ZTS) United States $67.467B 25.17
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $44.157B 22.63
BeOne Medicines - (ONC) Cayman Islands $30.596B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.886B 0.00
Summit Therapeutics (SMMT) United States $20.995B 0.00
Merck (MKKGY) Germany $16.698B 12.23
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.449B 11.90
Neurocrine Biosciences (NBIX) United States $13.210B 45.25
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.239B 0.00
Stevanato Group S.p.A (STVN) Italy $7.732B 47.28
Madrigal Pharmaceuticals (MDGL) United States $7.659B 0.00
Grifols, S.A (GRFS) Spain $6.937B 0.00
Ionis Pharmaceuticals (IONS) United States $6.807B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.310B 0.00
Hypermarcas (HYPMY) Brazil $3.178B 20.91
Crinetics Pharmaceuticals (CRNX) United States $2.987B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.589B 14.00
Catalyst Pharmaceuticals (CPRX) United States $2.583B 9.05
NewAmsterdam Pharma (NAMS) Netherlands $2.349B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.090B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.797B 0.00
Ocular Therapeutix (OCUL) United States $1.792B 0.00
ARS Pharmaceuticals (SPRY) United States $1.755B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.315B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.196B 23.92
Ardelyx (ARDX) United States $1.101B 0.00
ProKidney (PROK) United States $1.092B 0.00
Dyne Therapeutics (DYN) United States $1.061B 0.00
Enliven Therapeutics (ELVN) United States $1.053B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.024B 0.00
Collegium Pharmaceutical (COLL) United States $1.021B 5.51
Verve Therapeutics (VERV) United States $0.982B 0.00
Xeris Biopharma Holdings (XERS) United States $0.823B 0.00
KalVista Pharmaceuticals (KALV) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.751B 0.00
Zevra Therapeutics (ZVRA) United States $0.674B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.624B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.583B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Organogenesis (ORGO) United States $0.566B 0.00
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Bioventus (BVS) United States $0.545B 13.83
Siga Technologies (SIGA) United States $0.484B 10.12
Tourmaline Bio (TRML) United States $0.476B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.399B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.345B 9.31
Altimmune (ALT) United States $0.339B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.308B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Nektar Therapeutics (NKTR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.78
Nanobiotix S.A (NBTX) France $0.246B 0.00
OmniAb (OABI) United States $0.242B 0.00
Esperion Therapeutics (ESPR) United States $0.222B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.197B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.171B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Liminatus Pharma (LIMN) United States $0.140B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Korro Bio (KRRO) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Jupiter Neurosciences (JUNS) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 43.11
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.57
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00